Jump to navigation
Enter the article’s url One of our curators will take care of it as soon as possible!
Subscribe to our weekly newsletter.
High-risk, high-reward ideas in areas such as artificial intelligence, blockchain and synthetic biology are typical contenders for support from the EU’s new European Innovation Council.
The independent High-Level Group of Innovators recommends bringing all relevant EU funding schemes into a single, fit-for-purpose 'one-stop-shop' for innovation financing.
A new system must build cross-sector collaboration, lower barriers to working together, and create excitement and tangible know-how to attract investment.
How do evolving forms of digital scholarship fit into the current landscape and what are the implications for publishers?
Thomas Insel's biggest lesson from his shift from NIMH director to Silicon Valley entrepreneur: academic and technology company researchers should partner up.
Young firms struggle to compete as deep-pocketed companies like Facebook and Amazon clone products and consolidate their power.
Mountains, lakes, chocolate, fondue and banks? Right? Only partly.
How can evolutionary computation support journal editors?
As teachers launch personal brands and cast themselves as influencers, start-ups and tech giants alike are racing to cultivate them to spread their wares.
Approval of Novartis cancer drug is “historic,” FDA says
Leaders in the fields of AI and robotics, including Elon Musk and Google DeepMind’s Mustafa Suleyman, have signed a letter calling on the United Nations to ban lethal autonomous weapons.
A big waste of money or the engine of marketplace innovation? That's how some people see basic scientific research. Now a new study shows how basic research and inventions are connected.
Scholarly work cited in patent literature and the value of the patents as perceived by the applicants of 200 leading global research institutions.
Isaac Newton and Albert Einstein would have bridled under today's research funding bureaucracy. It's time to allow scientists to indulge their curiosity again.
MilliporeSigma wins a key step in its claims to “knock-in” DNA with the powerful tool.
As neural nets push into science, researchers probe back
Crispr inventor Jennifer Doudna talks about discovering the gene-editing tool, the split with her collaborator and the complex ethics of genetic manipulation.
There are probably much better reasons for creating a diverse team and organization than boosting creativity.
The world’s most potent technologists are stranded in today’s innovation ecosystem.
Disruption isn’t the only approach.